The latest CME article July 2018: “Assessment of bulbar function in amyotrophic lateral sclerosis: validation of a self-report scale” is online! Please log-in and browse to the LEARN  section on the EAN Website and answer the questions! All e-learning activities… Continue Reading

Despite its large use, recommendations for the use of brain F-18 FDG-PET in clinical practice were still lacking. The European Academy of Neurology (EAN) and the European Association of Nuclear Medicine (EANM) promoted a concerted action with 7 specialists from the two Societies and a group of facilitators in order to make the point on this issue. Extensive literature review and analysis of available data led, together with expert opinion (Delphi consensus), to deliver these recommendations that cover practically all the main brain neurodegenerative conditions causing cognitive impairment.

Please find below articles from Polish authors and co-authors that were published in the European Journal of Neurology

The Guideline will address important areas of dementia management where the medical doctor plays a pivotal role, which includes treatment of epilepsy in dementia, pain in dementia, treatment with antipsychotics in dementia, vascular risk factors in dementia and systematic medical follow-up in dementia.

Prof. F. Fazekas, President of the EAN and Prof. W. Struhal President of EFAS are pleased to announce that: EAN has joined with EFAS to promote Autonomic Nervous System (ANS) disorders in Europe and advance optimal care and management for… Continue Reading

The purpose I defined for my internship was to learn pathophysiology, clinical presentation, and treatment of a large spectrum of neuroimmunological diseases of the central and peripheral nervous system.

EFNA member association Dystonia Europe was among the winners of the Brain, Mind, and Pain Patient-Centred Innovation Grant, announced on Wednesday in Brussels.

GAMIAN-Europe, a patient-driven pan-European organization, represents the interests of persons affected by mental illness and advocates their right www.gamian.eu   GAMIAN Europe: European Parliament Interest Group on Mental Health, Well-being and Brain Disorders European Parliament, Brussels, Belgium, 16 May 2018… Continue Reading

On the occasion of the ninth European Conference on Rare Diseases & Orphan Products (ECRD) held in Vienna on 10th-12th May 2018, Prof. Marc Dooms, main author of the Declaration on Good Off-Label Use Practices (GOLUP), presented the 5 criteria for using medicines off-label that are laid down in the declaration. Many participants showed an interest in the declaration as well as various initiatives organized within the framework of the GOLUP-campaign.

WFN website: www.wfneurology.org Adress for the WBD: wbd2018@wfneurology.org. Clean air for brain health Mohammad Wasay MD, FRCP, FAAN (Aga Khan University, Karachi, Pakistan)
Wolfgang Grisold MD (Secretary General, WFN, Vienna, Austria) A link between environment and health has long been… Continue Reading

Last week EFNA attended the 4th European Academy of Neurology (EAN) Congress in Lisbon, along with more than 6700 neurologists! Once again, EFNA took this opportunity to bring together our members for our annual General Assembly. On Day 1 we… Continue Reading

        by Anna Sauerbier         Digital medicine and treatment development for brain disorders AZ, Lilly pull plug on Alzheimer’s disease trials France builds first Alzheimer’s ‘village’ in pioneering experiment Horizon Europe budget not big… Continue Reading

Prof. Elena Moro (EM): Dear Prof. Hallett, it is a great honor for me, as movement disorders specialist, to ask you few questions on behalf of the EAN members and for all EAN pages readers. In light of your Honorary Membership to the EAN, can you tell us what did make you choose “neurology” as the specialty to pursue? Prof. Mark Hallett (MH): I have been interested in the brain since I took a psychology course in high school.  I pursued neuroscience studies in college, but only decided to go into medicine about half way through college. 

Dear EAN Members, dear Colleagues, The 4th annual Congress of the European Academy of Neurology just held in Lisbon on June 16th - 19th was a spectacular event. More than 6,700 participants from 104 countries attended the meeting which covered the whole range of neurologic disorders in various formats, and offered altogether 42 scientific and 48 educational sessions. Besides several teaching courses and educational activities, the congress also comprised of 20 case-based workshops and interactive sessions, 7 hands-on courses, and 3 career development sessions.

For July 2018, we have selected: Thomalla G, Simonsen CZ, Boutitie G, et al., for the WAKE-UP Investigators. MRI-guided thrombolysis for stroke with unknown time of onset. NEJM May 16, 2018. doi:10.1056/NEJMoa1804355. Thrombolysis is currently performed in patients with acute ischemic stroke within a window of 4.5 hours since the symptoms’ onset. In about one third of the patients, the exact time of stroke onset is unknown, like in patients who wake up from sleeping.